1690O NKT2152, a novel oral HIF-2α inhibitor, in participants (pts) with previously treated advanced clear cell renal carcinoma (accRCC): Preliminary results of a phase I/II study
| Autor: | Jonasch, E., McGregor, B.A., Msaouel, P., Logan, T., Hall, E.T., Bilen, M.A., Falchook, G.S., Shuch, B., Zakharia, Y., Hauke, R., Gordon, M., Naqash, A-R., Ryan, C.W., Srinivasan, R., Xiao, J., Sun, W., Esguerra, M., Lu, G., Lager, J., Choueiri, T.K. |
|---|---|
| Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S1011-S1012 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|